Gossamer Bio (GOSS) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 1.95 | 1.41 | 0.67 | 0.14 | 0.49 | 2.21 | |||
Changes by years, y/y, % | -17% | -28% | -52% | -79% | +244% | -27.0% |
Gossamer Bio. Debt/EBITDA
Gossamer Bio. Debt/EBITDA, changes, %
Gossamer Bio (GOSS) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 0.66 | 0.52 | 0.23 | 2.42 | 2.21 | 2.21 | ||
Changes by years, y/y, % | +261% | +265% | -326% | -910% | +234% | |||
Changes by quarters, q/q, % | -320% | -22% | -56% | +964% | -9% |